Humacyte HUMA
NASDAQ HUMA
$0.66 -0.02 (-2.67%)
As of: Aug 21, 2026 · 2:24 PM EDT

Humacyte (HUMA) Net Margin Growth (1y) (2021 - 2026)

Humacyte (HUMA) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.89 Bn 131.04 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 86.05 Bn 78.06 Bn 3.93 Bn -763.00
3 Argenx Se 65.56 Bn 60.38 Bn 1.37 Bn 529.00
4 Moderna 55.46 Bn 50.32 Bn 52.00 Mn 4,168.00
5 BeOne Medicines 42.12 Bn 37.02 Bn 1.53 Bn 673.00
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn 2,208.00
7 BioNTech SE 27.70 Bn 9.30 Bn 668.28 Mn -1,652.00
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn 29,636.00
9 Royalty Pharma 27.38 Bn 26.54 Bn - -392.00
10 Humacyte 155.22 Mn 155.22 Mn -825,000.00 331,981.00

Historic Data

Download Data
DateValue
Jun 30, 2026 331,981.00
Mar 31, 2026 -129,085.00
Sep 30, 2021 -1.12 Mn